@article{Lewis:2026:10.1136/bmjresp-2025-003236,
author = {Lewis, A and Jung, P and Williams, P and Steinmann, J and Ingram, KA and Longley, N and Trivedi, P and Clarke, S and Lammin, H and Edwards, G and Koulopoulou, M and Sureshkumar, A and Moore, A and Pfeffer, PE and Reardon, L and Sorley, K and Kenman, J and DeLuca, B and Maguire, M and Smith, L-J and Elkin, S and Lound, A and Moth, L and Rickman, P and Alexander, S and Lohan, N and Garsin, E and Young, S and Harris, A and Watters, R and Lane, C and Nolan, CM and Conway, J and Man, WD-C and Banya, W and Anokye, N and Philip, KEJ and Cave, P and Hopkinson, NS},
doi = {10.1136/bmjresp-2025-003236},
journal = {BMJ Open Respir Res},
title = {Singing for lung health following completion of pulmonary rehabilitation: feasibility of a randomised controlled trial.},
url = {http://dx.doi.org/10.1136/bmjresp-2025-003236},
volume = {13},
year = {2026}
}

Download

TY  - JOUR
AB  - BACKGROUND: Pulmonary rehabilitation (PR) is a highly effective intervention for people with chronic respiratory disease; however, it is not known how best to sustain its benefits. Clinical trials are needed to establish if participation in singing for lung health (SLH) groups following PR will improve health-related quality of life, healthcare utilisation and exercise capacity compared with usual care. A feasibility study would help to guide development of these trials. METHODS: In a multicentre, mixed-methods randomised controlled feasibility trial, PR participants at four sites were prescreened at baseline assessment. An SLH taster session was included routinely as part of the PR programmes. Eligible PR completers were invited to take part in the trial and randomised to usual care or a 12-week SLH course. Feasibility outcomes included recruitment rate, intervention compliance (at least 8/12 sessions) and health economic analysis. Interviews with participants and study personnel were undertaken and thematic analysis of the results was completed. RESULTS: Between October 2022 and November 2023, 1311 patients were assessed to start PR, 838 completed. Of those completing, 243 were ineligible to take part (predominantly due to vaccination status and excluded diagnoses for PR referral), and 531 declined. 64 people (33 female, mean (SD) age 69 (12), 41 ethnically white, 33 with chronic obstructive pulmonary disease, 16 with asthma, 9 with interstitial lung disease, 6 with bronchiectasis) were recruited, with 30 (93.8%) SLH and 29 (90.6%) controls completing the study. 20 (62.5%) of the SLH group completed at least 8/12 SLH sessions. There was enthusiasm for a definitive trial from participants, clinicians and singing group leaders' perspectives, based on positive experiences of trial involvement. Improvements to recruitment strategy, intervention structure, outcome measures and staffing were suggested. CONCLUSIONS: A definitive randomised controlled trial of SLH post-PR
AU  - Lewis,A
AU  - Jung,P
AU  - Williams,P
AU  - Steinmann,J
AU  - Ingram,KA
AU  - Longley,N
AU  - Trivedi,P
AU  - Clarke,S
AU  - Lammin,H
AU  - Edwards,G
AU  - Koulopoulou,M
AU  - Sureshkumar,A
AU  - Moore,A
AU  - Pfeffer,PE
AU  - Reardon,L
AU  - Sorley,K
AU  - Kenman,J
AU  - DeLuca,B
AU  - Maguire,M
AU  - Smith,L-J
AU  - Elkin,S
AU  - Lound,A
AU  - Moth,L
AU  - Rickman,P
AU  - Alexander,S
AU  - Lohan,N
AU  - Garsin,E
AU  - Young,S
AU  - Harris,A
AU  - Watters,R
AU  - Lane,C
AU  - Nolan,CM
AU  - Conway,J
AU  - Man,WD-C
AU  - Banya,W
AU  - Anokye,N
AU  - Philip,KEJ
AU  - Cave,P
AU  - Hopkinson,NS
DO  - 10.1136/bmjresp-2025-003236
PY  - 2026///
TI  - Singing for lung health following completion of pulmonary rehabilitation: feasibility of a randomised controlled trial.
T2  - BMJ Open Respir Res
UR  - http://dx.doi.org/10.1136/bmjresp-2025-003236
UR  - https://www.ncbi.nlm.nih.gov/pubmed/41494697
VL  - 13
ER  - 

Download